Literature DB >> 19213748

Lymph node IL-18 expression in adult-onset Still's disease.

P Conigliaro, R Priori, M Bombardieri, C Alessandri, F Barone, C Pitzalis, I B McInnes, G Valesini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19213748     DOI： 10.1136/ard.2008.093781

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  14 in total

1.  [Recommendations for use of rituximab in patients with rheumatoid arthritis].

Authors:  A Rubbert-Roth; G R Burmester; T Dörner; A Gause
Journal:  Z Rheumatol       Date:  2014-03       Impact factor: 1.372

Review 2.  Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart.

Authors:  Yvan Jamilloux; Mathieu Gerfaud-Valentin; Fabio Martinon; Alexandre Belot; Thomas Henry; Pascal Sève
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

3.  [Rituximab].

Authors:  E Feist; T Dörner
Journal:  Z Rheumatol       Date:  2010-09       Impact factor: 1.372

4.  IL-18 Serum Level in Adult Onset Still's Disease: A Marker of Disease Activity.

Authors:  Serena Colafrancesco; Roberta Priori; Cristiano Alessandri; Carlo Perricone; Monica Pendolino; Giovanna Picarelli; Guido Valesini
Journal:  Int J Inflam       Date:  2012-06-18

Review 5.  Management of rheumatoid arthritis: consensus recommendations from the Hong Kong Society of Rheumatology.

Authors:  Chi Chiu Mok; Lai Shan Tam; Tak Hin Chan; Gavin K W Lee; Edmund K M Li
Journal:  Clin Rheumatol       Date:  2010-11-03       Impact factor: 2.980

6.  Adult-onset Still disease: a rare disorder with a potentially fatal outcome.

Authors:  Roberta Priori; Serena Colafrancesco; Angelica Gattamelata; Manuela Di Franco; Ugo Di Tondo; Guido Valesini
Journal:  Auto Immun Highlights       Date:  2010-07-10

7.  Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still's disease from sepsis.

Authors:  Tomohiro Koga; Remi Sumiyoshi; Kaori Furukawa; Shuntaro Sato; Kiyoshi Migita; Toshimasa Shimizu; Masataka Umeda; Yushiro Endo; Shoichi Fukui; Shin-Ya Kawashiri; Naoki Iwamoto; Kunihiro Ichinose; Mami Tamai; Hideki Nakamura; Tomoki Origuchi; Fumiaki Nonaka; Akihiro Yachie; Hideaki Kondo; Takahiro Maeda; Atsushi Kawakami
Journal:  Arthritis Res Ther       Date:  2020-05-07       Impact factor: 5.156

8.  Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.

Authors:  Clio P Mavragani; Evangelos G Spyridakis; Michael Koutsilieris
Journal:  Int J Inflam       Date:  2012-06-26

9.  Serum calprotectin--a promising diagnostic marker for adult-onset Still's disease.

Authors:  Qian Guo; Xicao Zha; Chun Li; Yuan Jia; Lei Zhu; Jianping Guo; Yin Su
Journal:  Clin Rheumatol       Date:  2015-11-07       Impact factor: 2.980

10.  Diagnostic and management of life-threatening Adult-Onset Still Disease: a French nationwide multicenter study and systematic literature review.

Authors:  Antoine Néel; Anaïs Wahbi; Benoit Tessoulin; Julien Boileau; Dorothée Carpentier; Olivier Decaux; Laurence Fardet; Guillaume Geri; Pascal Godmer; Cécile Goujard; Hervé Maisonneuve; Arnaud Mari; Jacques Pouchot; Jean-Marc Ziza; Cédric Bretonnière; Mohamed Hamidou
Journal:  Crit Care       Date:  2018-04-11       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.